Biogen Inc. buy Royal Bank of Canada
Start price
22.04.25
/
50%
€103.25
Target price
22.04.26
€195.75
Performance (%)
39.71%
Price
07:39
€144.25
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. has seen massive gains of 39.71%. This prediction currently runs until 22.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -1.327% | -1.327% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $221.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat